Bevacizumab Dosing: Weight-Based Administration
Bevacizumab is dosed based on body weight (mg/kg), not BSA, fixed dose, or capped dose. The standard dosing is weight-based and varies by indication and treatment schedule 1.
Standard Dosing Regimens by Indication
Colorectal Cancer
- 5 mg/kg IV every 2 weeks when combined with chemotherapy (FOLFOX, FOLFIRI) 2, 3
- 7.5 mg/kg IV every 3 weeks when combined with CapeOX 2
Ovarian Cancer
Brain Metastases/CNS Tumors
- 10 mg/kg IV every 2 weeks is suggested for steroid-dependent brain edema 5
Pharmacokinetic Rationale
The weight-based dosing approach is supported by population pharmacokinetic analyses showing that bevacizumab clearance varies with body weight 1, 6. After correcting for body weight, clearance is 0.23 L/day with linear pharmacokinetics across the 1-20 mg/kg dose range 1, 6.
Body weight is the primary covariate affecting both clearance and volume of distribution 1. Males have 26% higher clearance than females (0.26 vs 0.21 L/day), but this difference is accounted for by body weight adjustment 1.
Why Not BSA or Fixed Dosing?
Recent pharmacokinetic studies demonstrate that BSA-based dosing offers no substantial advantage over weight-based dosing for bevacizumab 7. The allometric scaling exponent for bevacizumab clearance based on body weight is appropriate, making weight-based dosing the optimal approach 6, 8.
Unlike some antibody-drug conjugates where BSA or adjusted ideal body weight may perform better 9, 10, bevacizumab's pharmacokinetics support the current weight-based paradigm 7, 6.
Dose Capping
No dose capping is recommended or routinely used for bevacizumab in standard practice 1. The FDA label does not specify any maximum dose cap, and clinical trials used weight-based dosing without upper limits 1.
Practical Administration
- Calculate dose as: Patient weight (kg) × prescribed mg/kg dose
- Administer as IV infusion over 30-90 minutes 4, 3
- Can be safely administered at 0.5 mg/kg/min (5 mg/kg over 10 minutes, 7.5 mg/kg over 15 minutes) 2
- Terminal half-life is approximately 20 days, with steady state reached in ~84-100 days 1, 8